These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20298337)

  • 1. COPD 'diagnosis' based on spirometric reference equations.
    Olofson J; Bake B; Tengelin MN; Houltz B
    Clin Respir J; 2008 Oct; 2(4):214-9. PubMed ID: 20298337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.
    Lindberg A; Bjerg A; Rönmark E; Larsson LG; Lundbäck B
    Respir Med; 2006 Feb; 100(2):264-72. PubMed ID: 15975774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction.
    Swanney MP; Ruppel G; Enright PL; Pedersen OF; Crapo RO; Miller MR; Jensen RL; Falaschetti E; Schouten JP; Hankinson JL; Stocks J; Quanjer PH
    Thorax; 2008 Dec; 63(12):1046-51. PubMed ID: 18786983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
    Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
    Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
    Medbø A; Melbye H
    Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FEV1/FVC and FEV1 for the assessment of chronic airflow obstruction in prevalence studies: do prediction equations need revision?
    Roche N; Dalmay F; Perez T; Kuntz C; Vergnenègre A; Neukirch F; Giordanella JP; Huchon G
    Respir Med; 2008 Nov; 102(11):1568-74. PubMed ID: 18657959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
    Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
    Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
    Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
    Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of bronchodilator use on the prevalence of COPD in population-based samples.
    Pérez-Padilla R; Hallal PC; Vázquez-García JC; Muiño A; Máquez M; López MV; de Oca MM; Tálamo C; Valdivia G; Pertuzé J; Jardim J; Menezes AM;
    COPD; 2007 Jun; 4(2):113-20. PubMed ID: 17530504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COPD among non-smokers - report from the obstructive lung disease in Northern Sweden (OLIN) studies.
    Hagstad S; Ekerljung L; Lindberg A; Backman H; Rönmark E; Lundbäck B
    Respir Med; 2012 Jul; 106(7):980-8. PubMed ID: 22498109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.
    Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ
    J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farming and the prevalence of non-reversible airways obstruction: results from a population-based study.
    Lamprecht B; Schirnhofer L; Kaiser B; Studnicka M; Buist AS
    Am J Ind Med; 2007 Jun; 50(6):421-6. PubMed ID: 17497693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender and chronic obstructive pulmonary disease in high-risk smokers.
    de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
    Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.
    Zhong N; Wang C; Yao W; Chen P; Kang J; Huang S; Chen B; Wang C; Ni D; Zhou Y; Liu S; Wang X; Wang D; Lu J; Zheng J; Ran P
    Am J Respir Crit Care Med; 2007 Oct; 176(8):753-60. PubMed ID: 17575095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study.
    Al Ghobain M; Alhamad EH; Alorainy HS; Al Kassimi F; Lababidi H; Al-Hajjaj MS
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1252-7. PubMed ID: 26459542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD.
    Schermer T; Heijdra Y; Zadel S; van den Bemt L; Boonman-de Winter L; Dekhuijzen R; Smeele I
    Respir Med; 2007 Jun; 101(6):1355-62. PubMed ID: 17098407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease.
    Shirtcliffe P; Marsh S; Travers J; Weatherall M; Beasley R
    Intern Med J; 2012 Jan; 42(1):83-8. PubMed ID: 20403069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits.
    Lindberg A; Jonsson AC; Rönmark E; Lundgren R; Larsson LG; Lundbäck B
    Respiration; 2005; 72(5):471-9. PubMed ID: 16210885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers.
    Miravitlles M; Ferrer M; Pont A; Luis Viejo J; Fernando Masa J; Gabriel R; Jiménez-Ruiz CA; Villasante C; Fernández-Fau L; Sobradillo V
    Respir Med; 2005 Aug; 99(8):985-95. PubMed ID: 15950139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.